London Medical Diagnostics Limited - Accounts to registrar (filleted) - small 18.2

REGISTERED NUMBER: 08866225 (England and Wales)

FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 JANUARY 2018

FOR

LONDON MEDICAL DIAGNOSTICS LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

DIRECTORS:

H Daya

Dr S Sridharan

Dr R W M Yates

REGISTERED OFFICE:

10 London Mews

London

W2 1HY

REGISTERED NUMBER:

08866225 (England and Wales)

ACCOUNTANTS:

Stein Richards

Chartered Accountants

10 London Mews

Paddington

London

W2 1HY

FIXED ASSETS

Tangible assets

3

8,859

11,812

CURRENT ASSETS

Cash at bank

27,779

26,182

CREDITORS

Amounts falling due within one year

4

2,301

4,789

NET CURRENT ASSETS

25,478

21,393

TOTAL ASSETS LESS CURRENT LIABILITIES

34,337

33,205

CAPITAL AND RESERVES

Called up share capital

5

99

99

Retained earnings

34,238

33,106

SHAREHOLDERS' FUNDS

34,337

33,205

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2018.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2018 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors on 3 April 2018 and were signed on its behalf by:

H Daya - Director

1.	STATUTORY INFORMATION

London Medical Diagnostics Limited is a private company, limited by shares , registered in England and Wales.

The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover represents fees agreed for the usage of assets when returned to company.

Rendering of services

Revenue for providing services are recognised when the service has been completed.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery

-

25% reducing balance

Financial instruments

The Company only enters into basic financial instruments transactions that result in the recognition of financial

assets and liabilities such as trade and other debtors and creditors and loans to related parties.

The basic financial debtors and liabilities as listed above are initially recognised at transaction price, unless the

arrangement constitutes a financing transaction, where the transaction is measured at the present value of the

future payments / receipts discounted at a market rate of interest. Such instruments are subsequently carried at

amortised cost using the effective interest method, less any impairment. An impairment review is undertaken

annually at the balance sheet date.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to

the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or

substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance

sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from

those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that

have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the

timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they

will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3.	TANGIBLE FIXED ASSETS

Plant and

machinery

£

COST

At 1 February 2017

and 31 January 2018

28,000

DEPRECIATION

At 1 February 2017

16,188

Charge for year

2,953

At 31 January 2018

19,141

NET BOOK VALUE

At 31 January 2018

8,859

At 31 January 2017

11,812

4.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.1.18

31.1.17

£

£

Taxation and social security

968

3,336

Other creditors

1,333

1,453

2,301

4,789

5.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

31.1.18

31.1.17

value:

£

£

99

Ordinary

£1

99

99